Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.

Literature DB >> 2856461

Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.

Abstract

The angiotensin-converting enzyme inhibitors, captopril, enalapril and perindopril, exert antiarrhythmic effects on early post-infarction arrhythmias in anaesthetized rats. These studies support the hypothesis that converting enzyme inhibitors could have a "cardioprotective" effect, but the doses used are probably "high" in relation to those therapeutically applicable to man.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1987 PMID： 2856461 DOI： 10.1007/bf02125833

Source DB: PubMed Journal: Cardiovasc Drugs Ther ISSN： 0920-3206 Impact factor: 3.727

19 in total

Review 1. Can inhibition of the renin-angiotensin system have a cardioprotective effect?

Authors: J B Michel; J C Dussaule; F Alhenc-Gelas; P Corvol; J Menard
Journal: J Cardiovasc Pharmacol Date: 1985 Impact factor: 3.105

2. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.

Authors: W H van Gilst; P A de Graeff; H Wesseling; C D de Langen
Journal: J Cardiovasc Pharmacol Date: 1986 Jul-Aug Impact factor: 3.105

3. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.

Authors: G Ertl; R A Kloner; R W Alexander; E Braunwald
Journal: Circulation Date: 1982-01 Impact factor: 29.690

Review 4. Prostaglandins and the cardiovascular system.

Authors: J R Vane
Journal: Br Heart J Date: 1983-05

5. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction.

Authors: C E Hock; L G Ribeiro; A M Lefer
Journal: Am Heart J Date: 1985-02 Impact factor: 4.749

6. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients.

Authors: M H Weinberger
Journal: J Cardiovasc Pharmacol Date: 1985 Impact factor: 3.105

7. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.

Authors: W H Van Gilst; P A De Graeff; J H Kingma; H Wesseling; C D De Langen
Journal: Eur J Pharmacol Date: 1984-04-13 Impact factor: 4.432

8. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.

Authors: M Laubie; P Schiavi; M Vincent; H Schmitt
Journal: J Cardiovasc Pharmacol Date: 1984 Nov-Dec Impact factor: 3.105

9. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

Authors: C Clark; M I Foreman; K A Kane; F M McDonald; J R Parratt
Journal: J Pharmacol Methods Date: 1980-06

Review 10. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.

Authors: R J Cody
Journal: Drugs Date: 1984-08 Impact factor: 9.546

5 in total

1. Lack of effect of perindoprilat, an angiotensin-I converting enzyme inhibitor, during coronary artery occlusion and reperfusion in the anesthetized dog.

Authors: C Ribuot; R Nadeau; N Yamaguchi; M Devissaguet; E Scalbert; L Rochette
Journal: Cardiovasc Drugs Ther Date: 1991-12 Impact factor: 3.727

5. Effect of the angiotensin-converting enzyme inhibitor, perindoprilat, and of angiotensin-II on the transient inward current of rabbit ventricular myocytes.

Authors: R Enous; L H Opie
Journal: Cardiovasc Drugs Ther Date: 1994-08 Impact factor: 3.727